Literature DB >> 6964282

Human posterior subcapsular cataracts.

J Eshagian.   

Abstract

Clinically and pathologically there are two kinds of posterior subcapsular cataracts: vacuolar-lacy and solid plaque. Vacuolar opacities occur in senile, diabetic, retinitis pigmentosa, steroid, and secondary cataracts (Elschnig pearls). Plaque opacities occur in congenital polar, myotonic dystrophy, and Turner syndrome (chromosome XO) cataracts. The vacuolar opacities tend to be more superficial (closer to the posterior capsule), whereas the plaque opacities are generally slightly deeper (more cortical). The vacuolar opacities show cellular proliferation of aberrantly migrated lens epithelial cells in the posterior pole which have added damage to the cataract by secretion of basement membrane, intra- and extra-cellular filaments, and release of cytolytic lysozymes causing liquefaction and necrosis. The plaque opacities are acellular. Both types of cataracts show breakdown of lens fibres into rounded up disorganized globules and some membranous whorls. The liquefied vacuolar opacity is more readily removed by extracapsular cataract extraction, but the retention of nucleated lens epithelial cells in the vacuolar type of opacity is the source of a secondary cataract or Hirchberg-Elschnig pearls which require a discussion or membranectomy to clear the visual axis. This article will review the salient features in the histopathology (light and electron microscopy) and morphology of PSC and amalgamate the findings reported by several investigators (Eshagian and Streeten, 1975; Eshagian, March, Goossens, and Rafferty, 1978, 1978; Eshagian, Rafferty, and Goossens, 1980, 1981; Eshagian, Rafferty, Goossens, and March, 1979; 1980; Streeten and Eshagian, 1978).

Entities:  

Mesh:

Year:  1982        PMID: 6964282

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  12 in total

1.  A new locus in chromosome 2q37-qter is associated with posterior polar cataract.

Authors:  Shan Ouyang; Linhan Gao; Lu Zhang; Yi Zheng; Wenping Cao; Guoyin Feng; Lin He; Ping Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

2.  Estrogen protects lenses against cataract induced by transforming growth factor-beta (TGFbeta).

Authors:  A M Hales; C G Chamberlain; C R Murphy; J W McAvoy
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

3.  A new locus for autosomal dominant posterior polar cataract in Moroccan Jews maps to chromosome 14q22-23.

Authors:  E Pras; O Mahler; V Kumar; M Frydman; N Gefen; E Pras; J F Hejtmancik
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

Review 4.  Oxidative damage and the prevention of age-related cataracts.

Authors:  David C Beebe; Nancy M Holekamp; Ying-Bo Shui
Journal:  Ophthalmic Res       Date:  2010-09-09       Impact factor: 2.892

5.  Expression of transforming growth factor-beta in cultured normal human lens epithelia cells.

Authors:  Yukan Huang; Houren Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  Aberrant basal fiber end migration underlies structural malformations in a streptozotocin-induced diabetic rat model.

Authors:  Anita Joy; Matthew S Currie; Sean T Donohue; Kristin J Al-Ghoul
Journal:  Exp Eye Res       Date:  2009-04-07       Impact factor: 3.467

7.  Posterior polar cataract: A review.

Authors:  Hatem Kalantan
Journal:  Saudi J Ophthalmol       Date:  2011-05-07

8.  Dynamic nature of posterior subcapsular cataract.

Authors:  G Adrien Shun-Shin; N P Brown; A J Bron; J M Sparrow
Journal:  Br J Ophthalmol       Date:  1989-07       Impact factor: 4.638

Review 9.  Pediatric cataract: challenges and future directions.

Authors:  Anagha Medsinge; Ken K Nischal
Journal:  Clin Ophthalmol       Date:  2015-01-07

10.  Glutathione and catalase suppress TGFbeta-induced cataract-related changes in cultured rat lenses and lens epithelial explants.

Authors:  Coral G Chamberlain; Kylie J Mansfield; Anna Cerra
Journal:  Mol Vis       Date:  2009-05-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.